367 related articles for article (PubMed ID: 27416996)
1. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
Cacicedo J; Navarro A; Del Hoyo O; Gomez-Iturriaga A; Alongi F; Medina JA; Elicin O; Skanjeti A; Giammarile F; Bilbao P; Casquero F; de Bari B; Dal Pra A
Br J Radiol; 2016 Nov; 89(1067):20160217. PubMed ID: 27416996
[TBL] [Abstract][Full Text] [Related]
2. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF
Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143
[TBL] [Abstract][Full Text] [Related]
3. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
5. (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.
Manca G; Vanzi E; Rubello D; Giammarile F; Grassetto G; Wong KK; Perkins AC; Colletti PM; Volterrani D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1360-75. PubMed ID: 26780912
[TBL] [Abstract][Full Text] [Related]
6. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
[TBL] [Abstract][Full Text] [Related]
7. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
8. Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Goel R; Moore W; Sumer B; Khan S; Sher D; Subramaniam RM
AJR Am J Roentgenol; 2017 Aug; 209(2):289-303. PubMed ID: 28731808
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma.
Arens AI; Troost EG; Schinagl D; Kaanders JH; Oyen WJ
Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):521-8. PubMed ID: 22019709
[TBL] [Abstract][Full Text] [Related]
10. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
Henriques de Figueiredo B; Barret O; Demeaux H; Lagarde P; De-Mones-Del-Pujol E; Kantor G; de Clermont-Gallerande H; Richaud P; Fernandez P
Radiother Oncol; 2009 Dec; 93(3):479-82. PubMed ID: 19880207
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings.
Plaxton NA; Brandon DC; Corey AS; Harrison CE; Karagulle Kendi AT; Halkar RK; Barron BJ
AJR Am J Roentgenol; 2015 Nov; 205(5):W519-31. PubMed ID: 26496574
[TBL] [Abstract][Full Text] [Related]
12. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
[TBL] [Abstract][Full Text] [Related]
14. Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.
Castaldi P; Leccisotti L; Bussu F; Miccichè F; Rufini V
Acta Otorhinolaryngol Ital; 2013 Feb; 33(1):1-8. PubMed ID: 23620633
[TBL] [Abstract][Full Text] [Related]
15. The potential role of non-FDG-PET in the management of head and neck cancer.
Heuveling DA; de Bree R; van Dongen GA
Oral Oncol; 2011 Jan; 47(1):2-7. PubMed ID: 21109481
[TBL] [Abstract][Full Text] [Related]
16. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis LW
Head Neck; 2005 Jun; 27(6):494-502. PubMed ID: 15772951
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
Rasmussen JH; Fischer BM; Aznar MC; Hansen AE; Vogelius IR; Löfgren J; Andersen FL; Loft A; Kjaer A; Højgaard L; Specht L
Br J Radiol; 2015 Apr; 88(1048):20140655. PubMed ID: 25634069
[TBL] [Abstract][Full Text] [Related]
20. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
Moeller BJ; Rana V; Cannon BA; Williams MD; Sturgis EM; Ginsberg LE; Macapinlac HA; Lee JJ; Ang KK; Chao KS; Chronowski GM; Frank SJ; Morrison WH; Rosenthal DI; Weber RS; Garden AS; Lippman SM; Schwartz DL
J Clin Oncol; 2009 May; 27(15):2509-15. PubMed ID: 19332725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
